Legal & General Group Plc Has $7.66 Million Position in Maximus, Inc. (NYSE:MMS)

Legal & General Group Plc lowered its holdings in Maximus, Inc. (NYSE:MMS) by 5.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 102,624 shares of the health services provider’s stock after selling 6,371 shares during the period. Legal & General Group Plc owned approximately 0.18% of Maximus worth $7,661,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of MMS. Vanguard Group Inc. raised its position in Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock valued at $488,829,000 after purchasing an additional 205,564 shares in the last quarter. Van Berkom & Associates Inc. increased its position in shares of Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock worth $93,792,000 after buying an additional 98,264 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock worth $74,700,000 after buying an additional 71,598 shares in the last quarter. Norges Bank bought a new stake in Maximus in the 4th quarter valued at about $71,443,000. Finally, Federated Hermes Inc. grew its holdings in shares of Maximus by 74.8% during the fourth quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider’s stock valued at $65,912,000 after buying an additional 377,705 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Insider Activity

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on MMS shares. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a report on Thursday, January 2nd. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

Maximus Price Performance

Shares of NYSE:MMS opened at $67.29 on Friday. The company’s fifty day moving average is $67.60 and its 200 day moving average is $75.41. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The stock has a market cap of $3.81 billion, a PE ratio of 14.47 and a beta of 0.68.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.78%. Maximus’s dividend payout ratio is 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.